Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 77

1.

Prognostic value of phosphorylated STAT3 in advanced rectal cancer: a study from 104 French patients included in the EORTC 22921 trial.

Monnien F, Zaki H, Borg C, Mougin C, Bosset JF, Mercier M, Arbez-Gindre F, Kantelip B.

J Clin Pathol. 2010 Oct;63(10):873-8. doi: 10.1136/jcp.2010.076414.

PMID:
20876317
[PubMed - indexed for MEDLINE]
2.

p53, deleted in colorectal cancer gene, and thymidylate synthase as predictors of histopathologic response and survival in low, locally advanced rectal cancer treated with preoperative adjuvant therapy.

Saw RP, Morgan M, Koorey D, Painter D, Findlay M, Stevens G, Clarke S, Chapuis P, Solomon MJ.

Dis Colon Rectum. 2003 Feb;46(2):192-202.

PMID:
12576893
[PubMed - indexed for MEDLINE]
3.

Prognostic significance of nuclear pSTAT3 in oral cancer.

Macha MA, Matta A, Kaur J, Chauhan SS, Thakar A, Shukla NK, Gupta SD, Ralhan R.

Head Neck. 2011 Apr;33(4):482-9. doi: 10.1002/hed.21468.

PMID:
20652980
[PubMed - indexed for MEDLINE]
4.

Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.

Tweedle EM, Khattak I, Ang CW, Nedjadi T, Jenkins R, Park BK, Kalirai H, Dodson A, Azadeh B, Terlizzo M, Grabsch H, Mueller W, Myint S, Clark P, Wong H, Greenhalf W, Neoptolemos JP, Rooney PS, Costello E.

Gut. 2010 Nov;59(11):1501-10. doi: 10.1136/gut.2009.196626.

PMID:
20947885
[PubMed - indexed for MEDLINE]
5.

Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.

Liersch T, Langer C, Ghadimi BM, Kulle B, Aust DE, Baretton GB, Schwabe W, Häusler P, Becker H, Jakob C.

J Clin Oncol. 2006 Sep 1;24(25):4062-8.

PMID:
16943523
[PubMed - indexed for MEDLINE]
Free Article
6.

Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.

Bertolini F, Bengala C, Losi L, Pagano M, Iachetta F, Dealis C, Jovic G, Depenni R, Zironi S, Falchi AM, Luppi G, Conte PF.

Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1455-61. Epub 2007 Apr 18.

PMID:
17445998
[PubMed - indexed for MEDLINE]
7.

Activation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosis.

Ryu K, Choy E, Yang C, Susa M, Hornicek FJ, Mankin H, Duan Z.

J Orthop Res. 2010 Jul;28(7):971-8. doi: 10.1002/jor.21088.

PMID:
20063378
[PubMed - indexed for MEDLINE]
8.

The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.

Perez RO, São Julião GP, Habr-Gama A, Kiss D, Proscurshim I, Campos FG, Gama-Rodrigues JJ, Cecconello I.

Dis Colon Rectum. 2009 Jun;52(6):1137-43. doi: 10.1007/DCR.0b013e31819ef76b.

PMID:
19581858
[PubMed - indexed for MEDLINE]
9.
10.

Pathologic stage is most prognostic of disease-free survival in locally advanced rectal cancer patients after preoperative chemoradiation.

Quah HM, Chou JF, Gonen M, Shia J, Schrag D, Saltz LB, Goodman KA, Minsky BD, Wong WD, Weiser MR.

Cancer. 2008 Jul 1;113(1):57-64. doi: 10.1002/cncr.23516.

PMID:
18442099
[PubMed - indexed for MEDLINE]
Free Article
11.

Mechanisms of oncogenesis in colon versus rectal cancer.

Kapiteijn E, Liefers GJ, Los LC, Kranenbarg EK, Hermans J, Tollenaar RA, Moriya Y, van de Velde CJ, van Krieken JH.

J Pathol. 2001 Sep;195(2):171-8.

PMID:
11592095
[PubMed - indexed for MEDLINE]
12.

Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma.

Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT.

J Clin Pathol. 2007 Jun;60(6):642-8. Epub 2006 Aug 10.

PMID:
16901975
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Value of expression of p21WAF1/CIP1 as a prognostic factor in advanced middle and lower rectal cancer patients treated with preoperative radio-chemotherapy.

Sogawa N, Takiguchi N, Koda K, Oda K, Satomi D, Kato K, Ishikura H, Miyazaki M.

Int J Oncol. 2002 Oct;21(4):787-93.

PMID:
12239617
[PubMed - indexed for MEDLINE]
14.

Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy.

Capirci C, Rampin L, Erba PA, Galeotti F, Crepaldi G, Banti E, Gava M, Fanti S, Mariani G, Muzzio PC, Rubello D.

Eur J Nucl Med Mol Imaging. 2007 Oct;34(10):1583-93. Epub 2007 May 15.

PMID:
17503039
[PubMed - indexed for MEDLINE]
15.

Activated STAT3 as a correlate of distant metastasis in prostate cancer: a secondary analysis of Radiation Therapy Oncology Group 86-10.

Torres-Roca JF, DeSilvio M, Mora LB, Khor LY, Hammond E, Ahmad N, Jove R, Forman J, Lee RJ, Sandler H, Pollack A.

Urology. 2007 Mar;69(3):505-9.

PMID:
17382154
[PubMed - indexed for MEDLINE]
16.

Activation of STAT3 in thymic epithelial tumours correlates with tumour type and clinical behaviour.

Chang KC, Wu MH, Jones D, Chen FF, Tseng YL.

J Pathol. 2006 Oct;210(2):224-33.

PMID:
16917804
[PubMed - indexed for MEDLINE]
17.

Correlation of CD133, OCT4, and SOX2 in rectal cancer and their association with distant recurrence after chemoradiotherapy.

Saigusa S, Tanaka K, Toiyama Y, Yokoe T, Okugawa Y, Ioue Y, Miki C, Kusunoki M.

Ann Surg Oncol. 2009 Dec;16(12):3488-98. doi: 10.1245/s10434-009-0617-z.

PMID:
19657699
[PubMed - indexed for MEDLINE]
18.

Expression of activated signal transducer and activator of transcription 3 predicts poor clinical outcome in gastric adenocarcinoma.

Lee J, Kang WK, Park JO, Park SH, Park YS, Lim HY, Kim J, Kong J, Choi MG, Sohn TS, Noh JH, Bae JM, Kim S, Lim do H, Kim KM, Park CK.

APMIS. 2009 Aug;117(8):598-606. doi: 10.1111/j.1600-0463.2009.02512.x.

PMID:
19664131
[PubMed - indexed for MEDLINE]
19.

GLUT-1 expression and response to chemoradiotherapy in rectal cancer.

Brophy S, Sheehan KM, McNamara DA, Deasy J, Bouchier-Hayes DJ, Kay EW.

Int J Cancer. 2009 Dec 15;125(12):2778-82. doi: 10.1002/ijc.24693.

PMID:
19569052
[PubMed - indexed for MEDLINE]
20.

Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis.

Flamini G, Curigliano G, Ratto C, Astone A, Ferretti G, Nucera P, Sofo L, Sgambato A, Boninsegna A, Crucitti F, Cittadini A.

Eur J Cancer. 1996 May;32A(5):802-6.

PMID:
9081357
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk